Squarepoint
ASTH icon

Squarepoint’s Astrana Health ASTH Stock Holding History

Squarepoint’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Buy
70,168
+42,354
+152% +$1M ﹤0.01% 2299
2025
Q4 		$690K Sell
27,814
-31,290
-53% -$831K ﹤0.01% 2930
2025
Q3 		$1.68M Sell
59,104
-36,453
-38% -$988K ﹤0.01% 2240
2025
Q2 		$2.38M Buy
95,557
+78,951
+475% +$2.22M ﹤0.01% 1976
2025
Q1 		$515K Sell
16,606
-21,699
-57% -$723K ﹤0.01% 3274
2024
Q4 		$1.21M Buy
+38,305
New +$1.82M ﹤0.01% 2878
2023
Q1 		– Sell
-29,321
Closed -$868K – 3901
2022
Q4 		$868K Sell
29,321
-14,771
-34% -$475K ﹤0.01% 1920
2022
Q3 		$1.72M Buy
44,092
+38,692
+717% +$1.77M 0.01% 1415
2022
Q2 		$208K Sell
5,400
-3,481
-39% -$132K ﹤0.01% 2455
2022
Q1 		$430K Buy
+8,881
New +$458K ﹤0.01% 2091
2021
Q1 		– Sell
-19,389
Closed -$354K – 3698
2020
Q4 		$354K Sell
19,389
-4,454
-19% -$80.1K ﹤0.01% 2085
2020
Q3 		$428K Buy
+23,843
New +$411K 0.01% 1544

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Squarepoint's ASTH Position: Q1 2026 in Review

Squarepoint increased its Astrana Health (ASTH) stake by 152% in Q1 2026, buying an estimated $1M and bringing the position to 70,168 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #2299.

Squarepoint first reported a position in ASTH in Q3 2020 and has held it in 12 quarters since. The position peaked at $2.38M in Q2 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Squarepoint held 70,168 shares of Astrana Health worth $1.72M as of Q1 2026.
  • Squarepoint bought 42,354 Astrana Health shares in Q1 2026, an estimated $1M.
  • Astrana Health made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2299 holding.
  • Squarepoint first reported a position in Astrana Health in Q3 2020 and has held it in 12 quarters since.
  • Squarepoint's Astrana Health position peaked at $2.38M in Q2 2025.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.